Abiopharma

📋 Laponis Adam (Officer) plans to sell 3K shares of Twist Bioscience Corp (at $40.00 each, total $120K) Filed: Jan 13, 2026 | ID: 000274

New Form SCHEDULE 13G - GridAI Technologies Corp. Filed: 2026-01-13 AccNo: 0001213900-26-003817 Size: 14 KB

📋 MIKKELSEN JAN MOLLER (Officer) plans to sell 87K shares of Ascendis Pharma A/S (at $211.99 each, total $18.4M) Filed: Jan 13, 2026 | ID: 000011

Travere Therapeutics Announces FDA Extends Review of sNDA for FILSPARI® (sparsentan) in FSGS

New Form 6-K/A - Inspira Technologies OXY B.H.N. Ltd Filed: 2026-01-13 AccNo: 0001213900-26-003780 Size: 124 KB

(99% Neutral) Virios Therapeutics Inc. (VIRI) Provides Update on investor for up to approximately $12

(99% Neutral) Co-Diagnostics Inc (CODX) Files Form 8-K

New Form 8-A12B - BriaCell Therapeutics Corp. Filed: 2026-01-13 AccNo: 0001493152-26-001969 Size: 401 KB

New Form 424B5 - Dogwood Therapeutics, Inc. Filed: 2026-01-13 AccNo: 0001104659-26-003197 Size: 401 KB

Law Offices of Frank R. Cruz Encourages agilon health, inc. (AGL) Shareholders To Inquire About Securities Fraud Class Action

GENFIT: Half-Year Report of Liquidity Contract with Crédit Industriel et Commercial

Attalon Launches as Independent Defense Technology Leader; Appoints John Bergeron as CEO to Strengthen Leadership in Precision Optics and Directed Energy

Perrigo Company plc (PRGO) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit

Law Offices of Howard G. Smith Encourages agilon health, inc. (AGL) Shareholders To Inquire About Securities Fraud Class Action

La France étend laccès national à lAAC pour le botensilimab + balstilimab dAgenus contre le cancer de lovaire et les sarcomes des tissus mous